WhatFinger

ISRAEL21c

ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media. The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.

Most Recent Articles by ISRAEL21c:

Israeli device freezes malignant liver and kidney tumors

Israeli device freezes malignant liver and kidney tumorsIn July 2012, ISRAEL21c wrote about a novel device from Caesarea-based IceCure Medical that was revolutionizing how American doctors remove benign breast lumps. The device uses minimally invasive cryoablation to destroy the tumor by freezing it rather than surgically removing it. Since then, IceCure’s ProSense system has expanded its applications dramatically.
- Wednesday, January 22, 2020

Sky-blue dye could help repair damaged heart tissue

Oren Yifa, left, and Prof. Eldad Tzahor at the Weizmann Institute of Science in Rehovot, Israel
Sky-blue dye could help repair damaged heart tissue
A non-toxic blue dye commonly used in biology labs helps repair damaged heart tissue in mice, say researchers at the Weizmann Institute of Science in Israel. As described in the Journal of Clinical Investigation Insight, a dye molecule called Chicago Sky Blue reduced scar size and improved heart function of adult mice following induced myocardial infarction (heart attack). Once damaged, heart muscle cells (cardiomyocytes) can never regenerate. But when research student Oren Yifa and his team injected Chicago Sky Blue into the post-heart attack mice in the molecular cell biology lab of Prof. Eldad Tzahor, the mice’s heart function improved. Their research suggests that the dye works in two ways: reducing inflammation and inhibiting the actions of a certain enzyme overproduced in heart disease.
- Friday, January 17, 2020

Finally, a pill that could fix the root cause of diabetes

Finally, a pill that could fix the root cause of diabetesOf the 463 million people in the world with diabetes, up to 95 percent have type 2 (T2D). In T2D, peripheral tissues – mostly muscles — are resistant to insulin, a hormone made by the pancreas to stabilize blood-sugar levels and enable the body to use and store sugar. Medications available today treat the symptoms and complications of T2D but do not solve the core problem of insulin resistance.
- Friday, January 17, 2020

Autism-related gene mutations occur in Alzheimer patients

Autism-related gene mutations occur in Alzheimer patientsResearchers believe that autism is caused by mutations in the egg or sperm or during pregnancy, particularly in the activity-dependent neuroprotective protein (ADNP) gene. A new Tel Aviv University study published in Molecular Psychiatry found that ADNP mutations continue to occur in old age and accumulate in the brains of Alzheimer’s disease patients.
- Wednesday, January 1, 2020

The diet and diabetes link: It’s not what you think

The diet and diabetes link: It’s not what you thinkCan diabetics throw away their insulin pumps simply by changing their diets? Israeli research published in Diabetes Care suggests that the standard diet recommended for diabetics is making things worse. Perhaps counter intuitively, eating a big breakfast of starches and sugars can help diabetics replace the need to inject insulin, while at the same time reducing the weight gain associated with diabetes and improving overall cardiovascular health.
- Thursday, December 19, 2019

Doctors perform historic surgery with aid of virtual reality

Doctors perform historic surgery with aid of virtual realityIt wasn’t going to be easy to remove a brain tumor threatening the life of 2-year-old Ari Ellman of San Francisco. Experts at several US hospitals weren’t even sure it was possible. But Ari’s tumor was removed, piece by piece, in a groundbreaking endonasal surgery lasting nearly 18 hours.
- Thursday, December 19, 2019

Israeli CO2-eating bacteria could help save the planet

Israeli CO2-eating bacteria could help save the planetIsraeli scientists have revealed a potential weapon in the battles against air pollution, deforestation and climate change: bacteria engineered to eat carbon dioxide (CO2) from the environment. Prof. Ron Milo’s plant and environmental sciences research lab at the Weizmann Institute of Science published a report on the study in Cell on November 27.
- Wednesday, December 11, 2019

How Israelis are going to help us hear better

How Israelis are going to help us hear betterAn air-raid siren awakened Erez Lugashi one night in 2014. As he ran for shelter, he wondered: What would a deaf person doin this situation? That question led the experienced Tel Aviv entrepreneur to start Abilisense. The idea was to develop software for IoT devices, such as smart watches, that sends vibrating or visual alerts to hearing-impaired individuals about anything from an air-raid siren to a crying baby.
- Wednesday, December 11, 2019


Israeli students win award for making honey without bees

Israeli students win award for making honey without beesWith the global population of bees in decline, honey could become a rare commodity on supermarket shelves. A team of 12 students from the Technion – Israel Institute of Technology has been working for the past year on the development of a bee-free honey. It’s produced by the bacterium Bacillus subtilis, which “learns” to make honey following reprogramming in a lab.
- Monday, November 25, 2019

10 promising developments that can help Alzheimer’s patients

10 promising developments that can help Alzheimer’s patientsNovember is Alzheimer’s Awareness Month. It’s a fitting time to look at the latest Israeli advances in preventing, diagnosing and treating the progressive and incurable brain disorder. Alzheimer’s disease (AD) is the most common cause of the 9.9 million new cases of dementia diagnosed each year worldwide. The disease primarily strikes the elderly population, affecting 30 percent of those over age of 85. AD impacts memory, thinking and language skills, and even the ability to carry out simple tasks.
- Monday, November 25, 2019

New device can sniff out deadly food allergens in 30 seconds

New device can sniff out deadly food allergens in 30 secondsIn a horrific story of terror at 10,000 feet, an 8-year-old girl with severe food allergies was exposed to pistachio shells that had been left, unbeknownst to her and her usually vigilant parents, in the seatback pocket of the row in front of her during a harrowing 2014 airplane ride home. The girl’s throat swelled – she was going into anaphylactic shock – and, despite her parents immediately injecting her with an emergency shot of epinephrine, she remained highly agitated during the remaining three hours of the flight.
- Wednesday, October 30, 2019

New invention to make hospital bedding germ-resistant

New invention to make hospital bedding germ-resistantHospital bedsheets and patient gowns are a major conduit for transferring dangerous bacteria estimated to infect 1.7 million hospitalized Americans and 3.5 million hospitalized Europeans every year. In the United States, hospital-acquired infections kill about 98,000 people yearly.
- Sunday, October 27, 2019

Clean up your indoor air with green walls, and grow veggies

Clean up your indoor air with green walls, and grow veggiesWant to insulate your office from the heat and cold outside, while purifying the air inside from potential toxins? Israeli startup Vertical Field is accomplishing that with sensor-controlled indoor and outdoor “green walls” installed by the likes of clients such as the Israeli offices of Google, Apple, Intel and Facebook. Indoor air pollution is an invisible but serious problem. High levels of carbon dioxide (CO2) in offices, classrooms, homes, trains and planes could be affecting our cognitive performance and in more severe cases may trigger inflammation or even kidney calcification and bone demineralization, according to a recent study published in Nature Sustainability.
- Monday, October 21, 2019

Engineered T cells could assassinate solid tumor cells

Tel Aviv University researchers, from left, Dr. Yaron Carmi, Diana Rasuluniriana and Dr. Peleg Ride.Immunotherapy is a promising cancer treatment that enhances the natural immune response. A new study led by Dr. Yaron Carmi of Tel Aviv University’s Sackler Faculty of Medicine finds that a form of immunotherapy — chimeric antigen receptors (CAR) T-cell therapy, used to treat the blood cancer leukemia– may work against other kinds of cancer as well.
- Monday, October 21, 2019

Is the microbiome about to change medicine for good?

Our bodies are home to about 100 trillion tiny microbesYour body is composed of about 10 trillion human cells. It’s also home to about 100 trillion tiny microbes, mainly bacteria, that wield astonishing power over your health. Many influences, from genetics, to diet and stress, contribute to the makeup of your microbiome — the collective community of microbes as personal as a fingerprint.
- Monday, October 21, 2019

New treatment offers hope for multiple myeloma and lymphoma

New treatment offers hope for multiple myeloma and lymphomaCancer is a devious adversary. It figures out all kinds of ways to hide from the body’s detection systems and grow unchecked until it’s too late to stop them. One of cancer’s most cunning methods of evading the immune system is to increase the frequency of a kind of cellular “train” – a protein called XPO1 – that makes regular back-and-forth trips in and out of the nucleus of a cell. The XPO1 protein’s job is to shuttle other proteins to the right stops on the line.
- Sunday, October 20, 2019

Israeli chatbot could diagnose early Alzheimer’s disease

A man in Brazil tests the Israeli Clara chatbot for early Alzheimer diagnosisHundreds of drugs have been developed to address Alzheimer’s disease, says Dr. Shahar Arzy, director of the computational neuropsychiatry lab at Hadassah Hebrew University Medical Center in Jerusalem. “Do you know how many have been found effective? Zero.” But if patients could be diagnosed in the preclinical stages of the disease, perhaps some of the new biological medications showing excellent results in other domains of neurology could be effective when applied early enough in the course of Alzheimer’s disease.
- Wednesday, October 2, 2019

Israeli breakthrough could turn hydrogen into the fuel of future

From left, Dr. Hen Dotan , Avigail Landman, Prof. Avner Rothschild and Prof. Gideon Grader at H2Pro in Caesarea. Photo by Chen Galili/Technion
From left, Dr. Hen Dotan , Avigail Landman, Prof. Avner Rothschild and Prof. Gideon Grader at H2Pro in Caesarea. Photo by Chen Galili/Technion
Electric battery-powered cars have stolen much of the buzz that hydrogen fuel-cell vehicles generated before the rise of Tesla and its fellow EV makers. A new technology developed by researchers from the Technion-Israel Institute of Technology in collaboration with the team that founded the popular Israeli-made phone app Viber promises to put hydrogen back on the grid. H2Pro uses a water-splitting technology called E-TAC (electrochemical thermally activated chemical) that draws hydrogen out of water by separating it from oxygen. A water molecule is made up of two hydrogen atoms and one oxygen atom.
- Thursday, September 26, 2019

‘Super shrimp’ may prevent a disease that affects millions

Could single-sex prawns serve the triple goal of alleviating poverty, protecting the environment and reducing disease? A monosex prawn bred by Ben-Gurion University’s Prof. Amir Sagiand his PhD student Tom Levy could make the winning trifecta possible. ‘Super shrimp’ may prevent a disease that affects millionsIn a groundbreaking study published in Scientific Reports, a research group headed by Sagi outlines the development of male Macrobrachium rosenbergii prawns with two female sex chromosomes and no male sex chromosome — a so-called “super shrimp” that produces only female offspring.
- Monday, September 23, 2019

Sponsored